Eur J Med Chem manuscript

01/08/2024

In collaboration with Mahboobi group (University of Regensburg, Germany) we modified Marbostat-100, an HDAC6 selective inhibitor, to significantly improve its hydrolytic stability and thus pharmacokinetic properties. Additionally, a crystal structure of the HDAC6/inhibitor complex provided mechanistic explanation for the high potency and stereoselectivity of the  compound. Congratulations to Lucka on spearheading the structural part of the study!

 

News